Clinical Trials Directory

Trials / Unknown

UnknownNCT05198128

Ovarian Hyperstimulation Syndrome Using Calcium Infusion

Ovarian Hyper Stimulation Syndrome Using Calcium Infusion

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
200 (estimated)
Sponsor
Al-Azhar University · Academic / Other
Sex
Female
Age
18 Years – 45 Years
Healthy volunteers
Not accepted

Summary

the incidence of OHSS and clinical outcomes after calcium IV infusion in high-risk women undergoing ART

Detailed description

Among assisted reproductive technologies (ART), ovarian hyperstimulation syndrome (OHSS) is a serious iatrogenic complication affects up to 30% of women undergoing ART and caries high risks of morbidity and mortality. Women with age younger than 35 years, those with history of polycystic ovary syndrome (PCOS), or having a history of previous OHSS are more susceptible to develop OHSS

Conditions

Interventions

TypeNameDescription
DRUGCalcium intravenous infsuionintravenous infusion of 10 % calcium gluconate 10 mL in 200 mL of physiologic saline on the day of ovum pickup, day 1,day 2, and day 3 after ovum pickup were administered in study group. Intravenous infusion was performed within 30 minutes
DRUG0.9 % saline0.9 % saline

Timeline

Start date
2022-03-01
Primary completion
2023-04-25
Completion
2023-05-10
First posted
2022-01-20
Last updated
2022-02-22

Source: ClinicalTrials.gov record NCT05198128. Inclusion in this directory is not an endorsement.

Ovarian Hyperstimulation Syndrome Using Calcium Infusion (NCT05198128) · Clinical Trials Directory